glp-1 news 2025 november trends 2025: real-world data, patient outcomes & future therapies Discount Wegovy is back on

& Krawetz, R

Parent(s) must be present for infusion

This behavior leads to mindless eating and can cause unnecessary weight accumulation

By reducing visceral fat, lowering blood pressure, and improving vascular function, these medications may reduce the burden on the heart

BMI requirements for each GLP-1 medication Semaglutide: Wegovy and Ozempic Semaglutide operates through two branded formulations with different approved indications, and the BMI requirements vary accordingly

The SELECT trial's cardiovascular benefit data (20% MACE reduction) has been particularly influential in changing payer attitudes, because preventing heart attacks and strokes saves money long-term